# Investigating the Feasibility and Implementation of Whole Genome Sequencing in Patients With Suspected Genetic Disorder

> **NCT03829176** · NA · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 200 (actual)

## Conditions studied

- Hereditary Disease
- Genetic Predisposition to Disease

## Interventions

- **GENETIC:** Whole Genome Sequencing

## Key facts

- **NCT ID:** NCT03829176
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-01
- **Primary completion:** 2020-10-01
- **Final completion:** 2020-10-01
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2020-11-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03829176

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03829176, "Investigating the Feasibility and Implementation of Whole Genome Sequencing in Patients With Suspected Genetic Disorder". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03829176. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*